Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme

Author： Raymond E.   Campone M.   Stupp R.   Menten J.   Chollet P.   Lesimple T.   Fety-Deporte R.   Lacombe D.   Paoletti X.   Fumoleau P.   for the EORTC Early Clinical Studies Group ECSG B.T.S.G..a.N.D.D.P..  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.38, Iss.10, 2002-07, pp. : 1348-1350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma

By Konstadoulakis Manousos   Antonakis Pantelis   Tsibloulis Basil   Stathopoulos George   Manouras Andreas   Mylonaki Despoina   Golematis Basil  

Cancer Chemotherapy and Pharmacology, Vol. 48, Iss. 5, 2001-11 ,pp. : 417-420

Springer Publishing Company

Access to resources Recommend Favorite

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

By Yan Zhao   Zhu Zhongling   Li Kai   Chen Peng   Wang Liuchun   Huang Chun   Xue Jinhuai   Liu Meijun  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma

By Ueno Hideki   Okada Shuichi   Okusaka Takuji   Ikeda Masafumi   Kuriyama Hitoshi  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis

By Lawson Karla   Anderson Kristen   Snyder Rachel   Simmons-Menchaca Marla   Atkinson Jeffrey   Sun Lu-Zhe   Bandyopadhyay Abhik   Knight Vernon   Gilbert Brian   Sanders Bob   Kline Kimberly  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 5, 2004-11 ,pp. : 421-431

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer

By Zhu Andrew   Clark Jeffrey   Ryan David   Meyerhardt Jeffrey   Enzinger Peter   Earle Craig   Fuchs Charles   Regan Eileen   Anbe Hiroshi   Houghton Michele   Zhang Joshua   Urrea Peter   Kulke Matthew  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 285-293

Springer Publishing Company

Access to resources Recommend Favorite